Gamida Cell Ltd has a consensus price target of $3.8, established from looking at the 30 latest analyst ratings. The last 3 analyst ratings were released from JMP Securities, Needham, and Piper Sandler on January 29, 2024, December 5, 2023, and November 15, 2023. With an average price target of $2.67 between JMP Securities, Needham, and Piper Sandler, there's an implied 6720.12% upside for Gamida Cell Ltd from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/29/2024 | GMDA | Buy Now | Gamida Cell | $0.04 | — | JMP Securities | Jason Butler | — | Downgrade | Market Outperform → Market Perform | Get Alert |
12/05/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 15245.27% | Needham | Gil Blum | → $6 | Reiterates | Buy → Buy | Get Alert |
11/15/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 5015.09% | Piper Sandler | Edward Tenthoff | $5 → $2 | Maintains | Overweight | Get Alert |
11/15/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 12687.72% | HC Wainwright & Co. | Vernon Bernardino | $11 → $5 | Maintains | Buy | Get Alert |
09/28/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 15245.27% | JMP Securities | Jason Butler | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
08/16/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 28032.99% | HC Wainwright & Co. | Vernon Bernardino | → $11 | Reiterates | Buy → Buy | Get Alert |
08/15/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 15245.27% | Needham | Gil Blum | → $6 | Reiterates | Buy → Buy | Get Alert |
06/30/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 15245.27% | Needham | Gil Blum | → $6 | Reiterates | Buy → Buy | Get Alert |
05/22/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 28032.99% | HC Wainwright & Co. | Vernon Bernardino | → $11 | Reiterates | Buy → Buy | Get Alert |
05/19/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 15245.27% | JMP Securities | Jason Butler | $8 → $6 | Maintains | Market Outperform | Get Alert |
05/16/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 15245.27% | Oppenheimer | Mark Breidenbach | $8 → $6 | Maintains | Outperform | Get Alert |
05/16/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 15245.27% | Needham | Gil Blum | → $6 | Reiterates | Buy → Buy | Get Alert |
04/20/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 15245.27% | Needham | Gil Blum | $8 → $6 | Maintains | Buy | Get Alert |
04/19/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 28032.99% | HC Wainwright & Co. | Vernon Bernardino | $5 → $11 | Maintains | Buy | Get Alert |
04/18/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 12687.72% | HC Wainwright & Co. | Vernon Bernardino | → $5 | Reiterates | → Buy | Get Alert |
04/17/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 20360.36% | JMP Securities | Jason Butler | → $8 | Maintains | Market Perform | Get Alert |
03/28/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 15245.27% | JMP Securities | Jason Butler | → $6 | Maintains | Market Outperform | Get Alert |
03/28/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 12687.72% | HC Wainwright & Co. | Vernon Bernardino | $22 → $5 | Maintains | Buy | Get Alert |
03/28/2023 | GMDA | Buy Now | Gamida Cell | $0.04 | 20360.36% | Oppenheimer | Mark Breidenbach | $10 → $8 | Maintains | Outperform | Get Alert |
The latest price target for Gamida Cell (NASDAQ: GMDA) was reported by JMP Securities on January 29, 2024. The analyst firm set a price target for $0.00 expecting GMDA to fall to within 12 months (a possible -100.00% downside). 16 analyst firms have reported ratings in the last year.
The latest analyst rating for Gamida Cell (NASDAQ: GMDA) was provided by JMP Securities, and Gamida Cell downgraded their market perform rating.
There is no last upgrade for Gamida Cell.
The last downgrade for Gamida Cell Ltd happened on January 29, 2024 when JMP Securities changed their price target from N/A to N/A for Gamida Cell Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gamida Cell, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gamida Cell was filed on January 29, 2024 so you should expect the next rating to be made available sometime around January 29, 2025.
While ratings are subjective and will change, the latest Gamida Cell (GMDA) rating was a downgraded with a price target of $0.00 to $0.00. The current price Gamida Cell (GMDA) is trading at is $0.04, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.